Old Web
English
Sign In
Acemap
>
Paper
>
702 The CDK4/6 inhibitor palbociclib enhances the vulnerability of Merkel cell carcinoma via the HIF2α pathway
702 The CDK4/6 inhibitor palbociclib enhances the vulnerability of Merkel cell carcinoma via the HIF2α pathway
2021
J. Lee
A Colunga
T. Pulliam
Kelly G. Paulson
V. Voillet
A. Berndt
Candice D. Church
Kristina Lachance
Song Park
N. Yamamoto
Maclean M. Cook
M. Kawasumi
Paul Nghiem
Keywords:
Merkel cell carcinoma
Cancer research
Vulnerability
Palbociclib
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]